A web-based tool that allows patients to report their symptoms to their clinicians in real time has been shown to increase survival rates in metastatic cancer patients.
Browsing: Disease Area > Lung
Available to view on demand
Live event: Wednesday 14th June 2017 at 07:00 [PST] 10:00 [EST] 15:00 [GMT]
Learn about a study that was accomplished as a means to explore the hypothesis that circulating concentrations of decoy receptors and/or ligands, as well as disease-specific ligand degradation all regulate RTK signaling in vivo.
Phase I data indicate that nivolumab significantly increases long-term survival in previously treated, advanced non-small-cell lung cancer.
In this case report the authors present systematic therapy as a multimodality tool in the management of patients with oligometastatic disease.
Prospective clinical trial results demonstrate that a biomarker blood test could detect lung cancer recurrence on average 6 months earlier than CT scans.
Metabolomic profiling could allow identification of cancer subtypes and precision therapy.
Researchers have demonstrated that individuals with non-small-cell lung cancer who are untreated have a significantly shorter overall survival rate.
Researchers have observed unique visual and behavioral differences among small cell lung cancer tumors; indicating the disease should not be uniformly treated.
Researchers have discovered that lung cancer patients could benefit from adjuvant chemotherapy up to 4 months after surgery.
A recent study has demonstrated that lung cancer patients suffering from depression are more likely to have a decreased tolerance to chemotherapy and lower overall survival.